Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent
- 31 March 1995
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 44 (3) , 207-213
- https://doi.org/10.1016/0306-9877(95)90137-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- Cancer chemotherapeutic and biologic agentsCA: A Cancer Journal for Clinicians, 1991
- Evolution of chemotherapyCA: A Cancer Journal for Clinicians, 1991
- Characterization of a new malignant human T‐cell line (PFI‐285) sensitive to ascorbic acidEuropean Journal of Haematology, 1989
- Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 actionCancer, 1989
- Vitamin C preferential toxicity for malignant melanoma cellsNature, 1980
- Toxicity, radiation sensitivity modification, and metabolic effects of dehydroascorbate and ascorbate in mammalian cells,Journal of Cellular Physiology, 1978
- Effects of tetraacetyl-bis-dehydroascorbic acid, a derivative of ascorbic acid, on ehrlich cells and hela cells (human carcinoma cells).Journal of Nutritional Science and Vitaminology, 1976
- Antitumor potency of ascorbic, dehydroascorbic or 2, 3-dike-togulonic acid and their action on deoxyribonucleic acidZeitschrift für Krebsforschung und Klinische Onkologie, 1971
- Synergistic Killing of Ehrlich Ascites Carcinoma Cells by Ascorbate and 3-Amino-1,2,4,-triazoleOncology, 1969